Science Explorer Back to mapMap
Discussion
Topic · Radiology, Nuclear Medicine and Imaging

Advances in Oncology and Radiotherapy

Advances in Oncology and Radiotherapy is a research topic within Radiology, Nuclear Medicine and Imaging. Science Explorer counts 23k research works in it since 1950. 10.5% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the global access to radiotherapy, including its role in cancer treatment, the expansion of access in low- and middle-income countries, workforce analysis, health economics, and infrastructure assessment. The papers also address the demand estimation for radiotherapy, medical education in oncology, and resource planning for optimal utilization.

  • Radiotherapy
  • Global Access
  • Cancer Treatment
  • Medical Education
  • Health Economics
  • Resource Planning
  • Workforce Analysis
  • Low- and Middle-Income Countries
  • Infrastructure Assessment
  • Demand Estimation
Research works
23k
fractional, since 1950
In the world top 10%
2.4k
per year above
Top-10% rate
10.5%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+13%
the tick is no change
Largest producer
United States
53% of the 10 largest, 2022-now
Advances in Oncology and Radiotherapy

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Advances in Oncology and Radiotherapy research?

By volume, the United States and the United Kingdom publish the most (1.9k and 372 works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.9k works
  2. 2 United Kingdom 372 works
  3. 3 India 231 works
  4. 4 Canada 215 works
  5. 5 China 207 works
  6. 6 Australia 157 works
  7. 7 Japan 142 works
  8. 8 Germany 135 works
  9. 9 Italy 127 works
  10. 10 France 115 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 53.2%United Kingdom: 10.2%India: 6.4%Canada: 5.9%6 others listed: 24.3%53%largest
United States1,930 · 53.2%United Kingdom372 · 10.2%India231 · 6.4%Canada215 · 5.9%6 others listed883 · 24.3%

Shares of the rows listed above, not of the whole node.

Which institutions lead Advances in Oncology and Radiotherapy research?

By volume in 2022-now, Harvard University publishes the most Advances in Oncology and Radiotherapy research, followed by The University of Texas MD Anderson Cancer Center and Mayo Clinic.

By volume, 2022-now

  1. 1 Harvard UniversityUnited States 77 works
  2. 2 The University of Texas MD Anderson Cancer CenterUnited States 49 works
  3. 3 Mayo ClinicUnited States 39 works
  4. 4 University of TorontoCanada 38 works
  5. 5 University of North Carolina at Chapel HillUnited States 35 works
  6. 6 Johns Hopkins UniversityUnited States 35 works
  7. 7 Memorial Sloan Kettering Cancer CenterUnited States 33 works
  8. 8 Stanford UniversityUnited States 27 works
  9. 9 University of California, San FranciscoUnited States 27 works
  10. 10 The Ohio State UniversityUnited States 24 works

Who are the leading researchers in Advances in Oncology and Radiotherapy?

The most-cited researchers publishing on Advances in Oncology and Radiotherapy include Ahmedin Jemal, Freddie Bray and Jacques Ferlay.

  1. 1 Ahmedin Jemal United States 761k citations
  2. 2 Freddie Bray France 550k citations
  3. 3 Jacques Ferlay France 486k citations
  4. 4 Hermann Brenner Germany 343k citations
  5. 5 Isabelle Soerjomataram France 327k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Advances in Oncology and Radiotherapy?

The most cited paper in Advances in Oncology and Radiotherapy is "Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries" (Claudia Allemani et al., 2018), with 6,323 citations. Next come "Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012" (5,286) and "Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer" (2,662).

Most cited papers
#PaperReleasedCitations
1 Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries Claudia Allemani et al. · The Lancet Open access595 authors 31 Jan 2018 6,323
2 Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012 Jacques Ferlay, Eva Steliarova‐Foucher, Joannie Lortet‐Tieulent et al. · European Journal of Cancer Open access 25 Feb 2013 5,286
3 Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer Ernest L. Mazzaferri, Sissy Meihua Jhiang · The American Journal of Medicine Nov 1994 2,662
4 Improved Survival with Preoperative Radiotherapy in Resectable Rectal Cancer Swedish Rectal Cancer Trial · New England Journal of Medicine Open access 3 Apr 1997 2,535
5 The Essential Physics of Medical Imaging Jerrold T. Bushberg, James Anthony Seibert, Edwin M. Leidholdt et al. · Medical Physics Open access Jul 2003 2,002
All 99 most cited papers, with filters and sorting

Where is Advances in Oncology and Radiotherapy research done?

The largest centres of Advances in Oncology and Radiotherapy research in 2022-now are London (United Kingdom), New York (United States), Boston (United States) and Houston (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Tampa.

Largest cities, 2022-now

  1. 1 LondonUnited Kingdom 117 works
  2. 2 New YorkUnited States 113 works
  3. 3 BostonUnited States 80 works
  4. 4 HoustonUnited States 73 works
  5. 5 TorontoCanada 63 works
  6. 6 PhiladelphiaUnited States 62 works
  7. 7 ChicagoUnited States 51 works
  8. 8 BaltimoreUnited States 46 works
  9. 9 ClevelandUnited States 39 works
  10. 10 MelbourneAustralia 38 works

Where it is the local speciality

  1. TampaUS · 21.9 works6.5×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Advances in Oncology and Radiotherapy than the world average.

See Advances in Oncology and Radiotherapy on the map

Where is the best place to study Advances in Oncology and Radiotherapy?

Among universities, judged by research, Harvard University, Johns Hopkins University and Aga Khan University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%mean 14.76%fractional works in this field (log) →share of work in the world top 10% →University of GhanaAga Khan UniversityJohns Hopkins Univer…Harvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 64.410.9%5.6×77 +4.3%
2Johns Hopkins UniversityUnited States 53.911.8%5.2×35 +30.7%
3Aga Khan UniversityPakistan 52.816.8%18.8×15 +52.3%
4University of GhanaGhana 52.518.8%8.3×9 +157.0%
5Queen's UniversityCanada 51.423.3%4.6×8 -28.6%
6Stanford UniversityUnited States 49.510.9%4.3×28 +39.7%
7University of TorontoCanada 47.010.8%4.3×38 -17.3%
8Washington University in St. LouisUnited States 46.918.9%5.3×17 +1.3%
9University of British ColumbiaCanada 46.412.3%3.2×17 +26.9%
10Temple University Health SystemUnited States 45.813.1%45.5×9 +127.9%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Advances in Oncology and Radiotherapy, country by country

Is Advances in Oncology and Radiotherapy research growing?

Output in 2022-2025 was 13% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Advances in Oncology and Radiotherapy.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Advances in Oncology and Radiotherapy as a percentage of every work published that year, 0.022% in 2024.

still counting0.010%0.020%0.030%Advances in Oncology and Radiotherapy0.022% in 202519801990200020102020

Fractional works of Advances in Oncology and Radiotherapy over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Advances in Oncology and Radiotherapy10.1% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Advances in Oncology and Radiotherapy. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.